STAG2 and neoplasm: Tumor DNA sequencing has shown that STAG2 mutations (Brohl et al., 2014; Crompton et al., 2014) or chromoplexy‐associated fusion gene genesis (Anderson et al., 2018) is associated with more aggressive clinical behavior.